EUVIMEDEUVIMED entdecken
Open Access

Efficacy of Bone Regeneration Cell Therapy Using Mesenchymal Stem Cells Originating from Embryonic Stem Cells in Animal Models; Bone Defects and Osteomyelitis

Jin-Ho Park, Han-Sol Bae, Ingeun Kim, Jiwoon Jung, Yoonho Roh, Dongbin Lee, Tae Sung Hwang, Hee-Chun Lee, June-Ho Byun

Tissue Engineering and Regenerative Medicine · 2025-01 · 22 (1) · 145-157

DOI: 10.1007/s13770-024-00683-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tissue Engineering and Regenerative Medicine, online erschienen am 29.11.2024. Verfasst von Jin-Ho Park und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Institut…. Hauptthemen laut MEDLINE: Osteomyelitis, Bone Regeneration, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Korean Fund for Regenerative Medicine, Korean Health Technology R&D Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Bone defects are commonly encountered due to accidents, diseases, or aging, and the demand for effective bone regeneration, particularly for dental implants, is increasing in our aging society. Mesenchymal stem cells (MSCs) are promising candidates for regenerative therapies; however, obtaining sufficient quantities of these cells for clinical applications remains challenging. DW-MSCs, derived from embryonic stem cells and developed by Daewoong Pharmaceutical, exhibit a robust proliferative capacity even after extensive culture. METHODS: This study explores the therapeutic potential of DW-MSCs in various animal models of bone defects. DW-MSCs were expanded for over 13 passages for in vivo use in rat and canine models of bone defects and osteomyelitis. The research focused on the in vivo osteogenic differentiation of DW-MSCs, the establishment of a fibrin-based system for bone regeneration, the assessment of bone repair following treatment in animal models, and comparisons with commercially available bone grafts. RESULTS: Results showed that DW-MSCs exhibited superior osteogenic differentiation compared to other materials, and the fibrinization process not only preserved but enhanced their proliferation and differentiation capabilities through a 3D culture effect. In both bone defect models, DW-MSCs facilitated significant bone regeneration, reduced inflammatory responses in osteomyelitis, and achieved effective bone healing. The therapeutic outcomes of DW-MSCs were comparable to those of commercial bone grafts but demonstrated qualitatively superior bone tissue restructuring. CONCLUSION: Our findings suggest that DW-MSCs offer a promising approach for bone regeneration therapies due to their high efficacy and anti-inflammatory properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteomyelitisBone RegenerationMesenchymal Stem CellsMesenchymal Stem Cell TransplantationCell DifferentiationDisease Models, AnimalOsteogenesisEmbryonic Stem CellsAnimalsRatsDogsRats, Sprague-DawleyCell- and Tissue-Based TherapyMaleCell Proliferation

Stichwörter der Autor:innen

Bone regenerationCell therapyFibrinizationMesenchymal stem cellOsteomyelitis model

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Institute of Medical Sciences, Gyeongsang National University, Jinju, 52727, R…
  • Department of Nutritional Science, University of Michigan School of Public Health, Ann Arbor, MI, 48109, USA.
  • Cell Therapy Center, Daewoong Pharmaceutical, Co., Ltd., Yongin, 17028, Republic of Korea.
  • Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University, Jinju, 52828, Republic of Korea.
  • Department of Veterinary Medical Imaging, College of Veterinary Medicine, Gyeongsang National University, Jinju, 52828, Republic of Korea.
  • Department of Convergence Medical Science, Gyeongsang National University, Jinju, 52727, Republic of Korea. surbyun@gnu.ac.kr.

Förderung

  • National Research Foundation of Korea
  • Korean Fund for Regenerative Medicine
  • Korean Health Technology R&D Project

Zitieren

APA

Park, J. H., Bae, H. S., Kim, I., Jung, J., Roh, Y., Lee, D., Hwang, T. S., Lee, H. C., & Byun, J. H. (2025). Efficacy of Bone Regeneration Cell Therapy Using Mesenchymal Stem Cells Originating from Embryonic Stem Cells in Animal Models; Bone Defects and Osteomyelitis. Tissue Engineering and Regenerative Medicine, 22(1), 145-157. https://doi.org/10.1007/s13770-024-00683-9

Vancouver

Park JH, Bae HS, Kim I, Jung J, Roh Y, Lee D, et al. Efficacy of Bone Regeneration Cell Therapy Using Mesenchymal Stem Cells Originating from Embryonic Stem Cells in Animal Models; Bone Defects and Osteomyelitis. Tissue Engineering and Regenerative Medicine. 2025;22(1):145-157. doi:10.1007/s13770-024-00683-9

BibTeX
@article{Park2025,
  author = {Park, Jin-Ho and Bae, Han-Sol and Kim, Ingeun and Jung, Jiwoon and Roh, Yoonho and Lee, Dongbin and Hwang, Tae Sung and Lee, Hee-Chun and Byun, June-Ho},
  title = {Efficacy of Bone Regeneration Cell Therapy Using Mesenchymal Stem Cells Originating from Embryonic Stem Cells in Animal Models; Bone Defects and Osteomyelitis},
  journal = {Tissue Engineering and Regenerative Medicine},
  year = {2025},
  volume = {22},
  number = {1},
  pages = {145--157},
  doi = {10.1007/s13770-024-00683-9}
}
Kostenlos starten →